Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic bilastine 20 mg vs BilaxTEN in healthy Thai volunteers (fasting)
TCTR20240708006Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bilastine in allergic rhinoconjunctivitis (ARC) and urticaria (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
bilastine
03
Conditions
allergic rhinoconjunctivitis (ARC)urticaria
Beyond the preview
Go deeper on TCTR20240708006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240708006.